Moreover, genetic and pharmacological activation of Nrf2 effectively protects against ischemic heart injury in animal models while Nrf2 deficiency exacerbates HF after myocardial infarction (Ashrafian et al., 2012; Cao et al., 2015). This evidence concerns the gene NFE2L2 and hydrops fetalis.